http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddc984d07806902647c4d9b88170b443
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cristofanilli |
| name | Massimo Cristofanilli |
| given-name | Massimo |
| organization-name | 2Department of Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Department Of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Thomas P. Slavin, Kar Wing Kevin Tsang, Susan L. Neuhausen, Stacy W. Gray, and Jeffrey N. Weitzel, City of Hope, Duarte; Kimberly C. Banks, Darya Chudova, Justin I. Odegaard, Rebecca J. Nagy, Christine E. Lee, and Richard B. Lanman, Guardant Health, Redwood City; Razelle Kurzrock, University of California, San Diego, Moores Cancer Center, San Diego, CA; Geoffrey R. Oxnard, Dana-Farber Cancer Institute; Aditya Bardia, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;... 12Northwestern University Feinberg School of Medicine, Chicago, Illinois. Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Division of Hematology and Oncology Robert H Lurie Comprehensive Cancer Center Northwestern University Chicago IL USA 4Department of Medicine, Hematology/Oncology Division, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; 11Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Fox Chase Cancer Center Department of Medical Oncology, 333 Cottman Ave, Philadelphia, PA 19111, USA. Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL From the Breast Cancer Medicine Service, Department of Pathology, Department of Radiology, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA; Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University Chicago, Chicago, United States Department of Breast Medical Oncology, Unit 424, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA. mcristof@mdanderson.org Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University, Chicago, IL, USA; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, United States. Electronic address: mac9795@med.cornell.edu. Charlotte Fribbens, Ben O’Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France;... Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA Authors' Affiliations: 1Translational Cancer Research Unit, Oncology Center, General Hospital Sint-Augustinus, Antwerp, Wilrijk; 2Department Oncology, KU Leuven, Leuven, Belgium; 3Morgan Welch Inflammatory Breast Cancer Program and Clinic, and 4Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, UMR891 Institut National de la Santé et de la Recherche Medicale (INSERM), Institut Paoli-Calmettes (IPC), Marseille, France; and 6Department of Medical Oncology, G. Morris Dorrance Jr. Endowed Chair in Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania From the Departments of Radiation Oncology, Biomathematics, Breast Medical Oncology, and Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. The University of Texas M. D. Anderson Cancer Center, Houston, TX Benedito A. Carneiro, Katharine Ann Collier, Sahithi Pamarthy, Vinay Sagar, Ricardo Costa, Timothy Taxter, Young Kwang Chae, Massimo Cristofanilli, Maha H. Hussain, Sarki A. Abdulkadir, and Francis J. Giles, Feinberg School of Medicine, Northwestern University; Timothy M. Kuzel, Rush University Medical Center, Chicago, IL; Rebecca J. Nagy, Stephen Fairclough, Justin Odegaard, and Richard B. Lanman, Guardant Health, Redwood City; and Alice Fan, Stanford University School of Medicine, Palo Alto, CA. Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA Feinberg School of Medicine Robert H. Lurie Cancer Center of Northwestern University Chicago IL USA Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Robert H Lurie Comprehensive Cancer Center, Chicago, IL 8Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois. Thomas Jefferson University Hospital, Philadelphia, PA 19107 Department of Medical Oncology, G. Morris Dorrance Jr. Endowed Chair in Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Room C315, Philadelphia, PA 19111-2497, USA From the Departments of Breast Medical Oncology, Radiation Oncology, Surgery, and Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX Authors' Affiliations: 1Breast Cancer Translational Research Laboratory; Departments of 2Breast Medical Oncology, 3Pathology, 4Biostatistics, 5Surgical Oncology, 6Molecular and Cellular Oncology, 7Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; and 8Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital, Taichung, Taiwan From the Departments of Breast Medical Oncology, Biostatistics and Applied Mathematics, Radiation Oncology, Surgical Oncology, and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Department of Oncology and Hematology, University of Modena e Reggio Emilia, Modena, Italy 1Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA 3Department of Medicine-Hematology and Oncology, Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois. University of Texas, MD Anderson Cancer Center Department of Breast Medical Oncology Unit 1354, 1155 Herman P Pressler, Houston, TX 77030 USA. 13Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, Illinois. 3Department of Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. From the Departments of Breast Medical Oncology, Biostatistics, Surgical Oncology, Pathology, Cardiology, and Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL (MC) Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA a Departments of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA From the Departments of Breast Medical Oncology, Biostatistics and Applied Mathematics, and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Gynecology and Obstetrics, University of Münster, Münster, Germany; Department of Obstetrics and Gynecology, Marseille Public Hospital System, Marseille; and Breast Cancer Unit and Translational Research Unit UPRES03535, Institut Gustave Roussy, Villejuif, France Northwestern University Clinical and Translational Sciences Institute (NUCATS), Northwestern University, Chicago, IL, USA 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. 5Breast Medical Oncology, M. D. Anderson Cancer Center, Houston, Texas; and From the Institut Salah Azaiez, Tunis, Tunisia; M. D. Anderson Cancer Center, Houston, TX; GlaxoSmithKline, Collegeville, PA; and Duke University Medical Center, Durham, NC. 1Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.; 2Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. 2M.D. Anderson Cancer Center, Houston, Texas; a Departments of Breast Medical Oncology, Houston, Texas, USA Division of Hematology and Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL, USA 1Departments of Breast Medical Oncology, 1Department of Breast Medical Oncology and Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Currently at Division of Hematology-Oncology at Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, USA Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111-2497, USA. massimo.cristofanilli@fccc.edu Department of Medicine, Hematology/Oncology Division, Feinberg School of Medicine, Northwestern University; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States Department of Medical Oncology, Lurie Cancer Center at the Feinberg School of Medicine, Northwestern University, Chicago, IL, USA From The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Immunicon Corp, Huntingdon Valley, PA. Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, United States of America; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, United States of America Authors' Affiliations: 1Center for Functional Cancer Epigenetics, 2Department of Medical Oncology, Dana-Farber Cancer Institute; 3Department of Medicine, Brigham and Women's Hospital; Departments of 4Pathology and 5Breast Medical Oncology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston; 6Foundation Medicine, Cambridge, Massachusetts; 7Departments of Investigational Cancer Therapeutics, Surgical Oncology, and 8Systems Biology and Breast Medical Oncology, The University of MD Anderson Cancer Center, Houston, Texas; 9Fundacion de Investigacion INCLIVA-Institute for Health Research; 10Departments of Hematology-Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain; 11Jefferson Breast Care Center, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania; 12Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú; 13Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; 14Teva Pha Department of Medicine Northwestern University Feinberg School of Medicine Chicago Illinois Robert H Lurie Comprehensive Cancer Center; Northwestern University; Chicago; USA Thomas Jefferson University Hospital Kimmel Cancer Center, Department of Medical Oncology 1025 Walnut Street Philadelphia Pennsylvania 19107 Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine, Chicago, Illinois, USA Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA. Authors' Affiliations: 1Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 2University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico; 3Arena Oncology Associates, Great Neck, New York; 4Scripps Health, San Diego, California; 5Grupo de Trabajo de Oncologia Médica, Caracas, Venezuela; 6AstraZeneca, Macclesfield, United Kingdom; 7Targeted Molecular Diagnostics, Westmont, Illinois; and 8University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine , New York, NY , USA 1Departments of Breast Medical Oncology, Pathology, Surgical Oncology, Radiation Oncology and Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas and 1Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.; 2Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. Department of Medical Oncology; Thomas Jefferson University-Kimmel Cancer Center; Philadelphia Pennsylvania 2Department of Breast Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Hematopathology and 2Breast Medical Oncology, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, 3Department of Molecular Pathology and Metastasis Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II; 5Department of Breast Oncology, National Cancer Institute “Fondazione Pascale”, Naples, Italy; 6Department of Medical Oncology, National Cancer Institute, Bratislava, Slovakia; and 7Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania Northwestern University, Evanston, Illinois, USA From the Institute of Cancer Research and Royal Marsden Hospital, London (N.C.T.); David Geffen School of Medicine at University of California, Los Angeles, Santa Monica (D.J.S.), and Pfizer Oncology, San Diego (X.H.) — both in California; National Cancer Center, Goyang-si, Gyeonggi-do (J.R.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul (S.-A.I.) — both in South Korea; Dnipropetrovsk Medical Academy, City Multiple-Discipline... The University of Texas, M.D. Anderson Cancer Center, Houston, TX Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston; Robert G. Mennel, Texas Oncology, Dallas, TX; Massimo Cristofanilli, Thomas Jefferson University–Kimmel Cancer Center, Philadelphia, PA; Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN;... From the Departments of Breast Medical Oncology, Ophthalmology, Laboratory Medicine, Pathology, and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. 10Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. Lynn Sage Breast Cancer Program, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA Division of Medicine-Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois Department of Breast Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Tex. 9Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois. 1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.; 2Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA 1Breast Medical Oncology, Departments of Robert H. Lurie Comprehensive Cancer Centre, Feinberg School of Medicine, Chicago, IL Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New York, New York; NewYork-Presbyterian Hospital, New York, New York Department of Breast Medical Oncology The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 Division of Medical Oncology, Internal Medicine Department, Weill Cornell Medicine, New York, NY Department of Medicine, Division of Hematology-Oncology,Weill Cornell Medicine , New York, NY , USA 2Breast Medical Oncology, 2Breast Medical Oncology, and From The University of Texas M.D. Anderson Cancer Center, Houston, TX; and Brown University, Providence, RI Developmental Therapeutics Program of the Division of Hematology Oncology, Chicago, IL, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA; Northwestern University Feinberg School of Medicine, Chicago, IL, USA Lurie Cancer Center, Northwestern University, Chicago, IL, 60611, USA Department of Breast Medical Oncology, Box 56, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030. Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL From The University of Texas M. D. Anderson Cancer Center, Houston, TX; Nuvera Biosciences, Woburn, MA; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy; Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; University Pierre et Marie Curie Tenon Hospital, Paris; and Institut Gustave-Roussy, Villejuif, France. Fox Chase Cancer Center, Philadelphia, PA 4Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois. Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States; The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States From The University of Texas M.D. Anderson Cancer Center, Houston, TX; The University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The Cleveland Clinic, Cleveland, OH; Washington University, St Louis, MO; University of Arizona, Phoenix, AZ; and Immunicon Corporation, Huntingdon Valley, PA g Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA Department of Medical Oncology, Thomas Jefferson University, 1025 Walnut St, Suite 700, Philadelphia, PA 19107, USA Department of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. mcrisdtof@mdanderson.org Department of Medicine‐Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Northwestern University Chicago Illinois USA Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA Weill Cornell Medicine, New York, NY, USA 5Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL. Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois 7Lurie Comprehensive Cancer Center, Chicago, Illinois. 2The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Authors' Affiliations: Departments of 1Hematopathology and 2Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 3Biostatistics and Bioinformatics Facility, 4Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and Departments of 5Biostatistics and 6Medical Oncology, Institut Curie, Paris, France International Society of Liquid Biopsy, Granada, Spain; Robert H. Lurie Cancer Comprehensive Cancer Center of Northwestern University, Chicago, Illinois Department of Breast Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 6Breast Medical Oncology, and Lynn Sage Breast Cancer Program Department of Medicine‐Hematology and Oncology Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago IL USA 6Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, 710 N Fairbanks Court, Suite 8-250A, Chicago, IL, 60611, USA. The University of Texas M.D. Anderson Cancer Center, Houston, TX Department of Breast Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA From the Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. |
Incoming Links
Total number of triples: 520.